NYSE:TEVA

Teva Pharmaceutical Industries Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy TEVA

*Your capital is at risk

$32.83

-0.250 (-0.756%)

At Close: Jun 03, 2026

Teva Pharmaceutical Industries Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -58.65. In total, the insiders bought 2.18M and sold 783.74K TEVA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-58.65
● Buy	2.18M shares
● Sell	783.74K shares
76% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Mar 03, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -58.65. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (76% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 04, 2026 Buy	Restricted Share Units A-Award	Fox Christine EVP, U.s. Commercial	Officer	50 643 Value: $1.67M
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Fox Christine EVP, U.s. Commercial	Officer	9 098 Value: $295.4K
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Fox Christine EVP, U.s. Commercial	Officer	20 461 Value: $673.4K
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Kalif Eliyahu Sharon EVP, Chief Financial Officer	C-Suite Officer	33 512 Value: $1.10M
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Kalif Eliyahu Sharon EVP, Chief Financial Officer	C-Suite Officer	23 251 Value: $765.2K
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Hughes Eric A See "remarks"	Officer	23 251 Value: $765.2K
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Weiss Amir Chief Accounting Officer	Officer	10 679 Value: $351.4K
Mar 04, 2026 Buy	Restricted Share Units A-Award	Weiss Amir Chief Accounting Officer	Officer	11 280 Value: $371.2K
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Weiss Amir Chief Accounting Officer	Officer	5 650 Value: $185.9K
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Francis Richard D President And CEO	CEO / President	50 223 Value: $1.65M
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Francis Richard D President And CEO	CEO / President	23 393 Value: $759.4K
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Weiss Amir Chief Accounting Officer	Officer	10 679 Value: $351.4K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Savage Brian Interim Chief Legal Officer	Officer	1 489 Value: $48.3K
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Savage Brian Interim Chief Legal Officer	Officer	4 744 Value: $156.1K
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Weiss Amir Chief Accounting Officer	Officer	5 650 Value: $185.9K
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Savage Brian Interim Chief Legal Officer	Officer	3 766 Value: $123.9K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Savage Brian Interim Chief Legal Officer	Officer	1 186 Value: $38.5K
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Savage Brian Interim Chief Legal Officer	Officer	4 744 Value: $156.1K
Mar 04, 2026 Buy	Restricted Share Units A-Award	Francis Richard D President And CEO	CEO / President	136 736 Value: $4.50M
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Francis Richard D President And CEO	CEO / President	50 223 Value: $1.65M
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Daniell Richard EVP, Europe Commercial	Officer	33 512 Value: $1.10M
Mar 04, 2026 Buy	Ordinary Shares M-Exempt	Daniell Richard EVP, Europe Commercial	Officer	20 461 Value: $673.4K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Daniell Richard EVP, Europe Commercial	Officer	20 461 Value: $664.3K
Mar 04, 2026 Sell	Ordinary Shares S-Sale	Daniell Richard EVP, Europe Commercial	Officer	37 372 Value: $1.23M
Mar 04, 2026 Buy	Restricted Share Units M-Exempt	Daniell Richard EVP, Europe Commercial	Officer	20 461 Value: $673.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and cr...

Read Full Profile Here